Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED)
Clinical trial NCT00378599 · COMPLETED
Trial details
- NCT number
- NCT00378599
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2009-07-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.